Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Cervical Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplastic Cells, Circulating 1Neoplasm, Residual 1Leukemia, Hairy Cell 1Leukemia 1Kidney Neoplasms 1Hypoxia 1Health Status Unknown 1Colonic Neoplasms 1Carcinoma in Situ 1Brain Neoplasms 1Anus Neoplasms 1

Interventions

belzutifan 7Nivolumab 7pembrolizumab 6Ipilimumab 5Surveys and Questionnaires 3lenvatinib 2cabozantinib 2Radiosurgery 2Paclitaxel 2Everolimus 2Carboplatin 2pazopanib 1palbociclib 1liposomal doxorubicin 1guadecitabine 1fludarabine phosphate 1endothelial PAS domain-containing protein 1 1durvalumab 1cemiplimab 1atezolizumab 1aldesleukin 1X-Rays 1Technetium Tc 99m Sestamibi 1Taxes 1Sunitinib 1Spermine Synthase 1Social Determinants of Health 1Single Photon Emission Computed Tomography Computed Tomography 1Radiotherapy 1Radionuclide Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Kidney Neoplasms × Magnetic Resonance Imaging × Clear all
NCT06116253 2026-05-08

Advanced Diffusion Imaging in Renal Cancer Patients

NYU Langone Health

Phase NA Active not recruiting
39 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡